Company profile: Pixelligent
1.1 - Company Overview
Company description
- Provider of synthetic metal oxide nanocrystal materials and a proprietary development and manufacturing platform. PixClearProcess controls nanocrystal size, uniformity, and dispersibility. Offerings include PixClear titania and zirconia compounds for next-gen displays, XR, sensors, and optics; PixNIL high-index nanoimprint formulations; PixJet inkjettable formulations for electronic displays; and PixCor UV/titania stability formulations.
Products and services
- PixClear Titania and Zirconia Designer Compounds: Custom-engineered metal oxide nanocrystal formulations and dispersions that enhance the performance of next-gen displays, XR devices, sensors, and optics, supplying titania and zirconia chemistries
- PixClearProcess: Fully scaled development and manufacturing platform that controls nanocrystal size, uniformity, and dispersibility, enabling PixClear materials to be engineered for seamless integration into the most common manufacturing
- PixNIL Formulations: High-refractive-index materials architected for nanoimprint lithography applications and compatible with leading thin-film application tools
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Pixelligent
Silence Therapeutics
HQ: United Kingdom
Website
- Description: Provider of RNA technology and a proprietary genetic medicine platform leveraging RNA interference to target and silence disease-associated genes without altering DNA. Developing siRNA therapies including zerlasiran (SLN360) to reduce high lipoprotein(a) and divesiran (SLN124) targeting TMPRSS6 to manage iron levels and treat polycythemia vera by increasing hepcidin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Silence Therapeutics company profile →
Nanomi
HQ: The Netherlands
Website
- Description: Provider of microsphere and nanoparticle manufacturing and long-acting release medicine development, leveraging proprietary Microsieve technology for uniform particle size and precise extended dosing, and Monosphere technology for biodegradable monodisperse particles that encapsulate active compounds for controlled, long-term release; develops products in-house and in collaboration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanomi company profile →
Blueberry Therapeutics
HQ: United Kingdom
Website
- Description: Provider of nanomedicine-enabled topical treatments for dermatological conditions, including antifungal sprays BB2603 for onychomycosis and BB1202 for tinea pedis that enhance drug penetration with lower doses, and BB1511 cream for atopic dermatitis to support skin barrier and reduce inflammation; also conducts clinical trials to test safety and efficacy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Blueberry Therapeutics company profile →
Aspex
HQ: United States
Website
- Description: Provider of rugged scanning electron microscopes (SEMs) and related services for environmentally demanding military, industrial, and factory floor applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aspex company profile →
Vironova
HQ: Sweden
Website
- Description: Provider of solutions for sub-visible particle analysis, offering products and services used in the development of particles for vaccines, drug delivery and gene therapy, as well as viral safety testing and material quality control; founded in 2005 from interdisciplinary research at the Karolinska Institute in Stockholm, Sweden.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vironova company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Pixelligent
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Pixelligent
2.2 - Growth funds investing in similar companies to Pixelligent
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Pixelligent
4.2 - Public trading comparable groups for Pixelligent
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →